Explore how early design decisions in MSC therapy development impact scalability, cost, and regulatory success. Mesenchymal stromal cell (MSC) therapies continue to show promise across a wide range of indications, but translating early scientific success into scalable, reproducible, and commercially viable products remains a persistent challenge. Many of the o... [11353 chars]
2026 Copyright © News-Matic.com. All Rights Reserved
